Sirolimus therapy in cardiac transplantation
Authors:
- 6 May 2003
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (3) , S171-S176
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Sirolimus: a comprehensive reviewExpert Opinion on Pharmacotherapy, 2001
- Cardiac allograft vasculopathyCurrent Opinion in Cardiology, 2000
- DIFFERENTIAL EFFECTS OF CYCLOSPORINE A, METHYLPREDNISOLONE, MYCOPHENOLATE, AND RAPAMYCIN ON CD154 INDUCTION AND REQUIREMENT FOR NF??BTransplantation, 2000
- Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickeningTransplant International, 2000
- IMMUNOSUPPRESSIVE THERAPYSurgical Clinics of North America, 1999
- Rapamycin inhibits vascular smooth muscle cell migration.Journal of Clinical Investigation, 1996
- RAPAMYCIN INHIBITS TRANSPLANT VASCULOPATHY IN LONG-SURVIVING RAT HEART ALLOGRAFTSTransplantation, 1995
- EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506Transplantation, 1995
- REVERSAL OF ONGOING HEART, KIDNEY, AND PANCREAS ALLOGRAFT REJECTION AND SUPPRESSION OF ACCELERATED HEART ALLOGRAFT REJECTION IN THE RAT BY RAPAMYCINTransplantation, 1993
- THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1Transplantation, 1993